Personal Protective Equipment Market Surges to USD 115.66 Billion by 2031, Propelled by 4.34% CAGR - Verified Market Research®
August 20, 2024 10:00 ET
|
Verified Market Research
Lewes, Delaware, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The Global Personal Protective Equipment Market Size is projected to grow at a CAGR of 4.34% from 2024 to 2031, according to a new report published...
UK Health Check-up (Blood, Urine, Body Fluid, Imaging) Market Size, Share & Trends Analysis Report 2024-2030
August 20, 2024 09:33 ET
|
Research and Markets
Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "UK Health Check-up Market Size, Share & Trends Analysis Report By Test Type (Blood, Urine, Body Fluid Tests, Imaging-based Tests), By End-use...
U.S. ADHD And Autism Clinics Market Research 2024-2030: Advancements in Treatment Options & Growing Government Support & Funding
August 20, 2024 09:21 ET
|
Research and Markets
Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "U.S. ADHD And Autism Clinics Market Size, Share & Trends Analysis Report By Condition (Attention Deficit Hyperactivity Disorder (ADHD), Autism...
U.S. Healthcare Training and Education Services Outsourcing Market Trends Analysis Report 2024-2030
August 20, 2024 09:16 ET
|
Research and Markets
Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "U.S. Healthcare Training And Education Services Outsourcing Market Size, Share & Trends Analysis Report By Service (Training and Development,...
North America Citric Acid Market Report 2024-2032
August 20, 2024 09:07 ET
|
Research and Markets
Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "North America Citric Acid Market Report by Application (Food and Beverages, Household Detergents and Cleaners, Pharmaceuticals, and Others), Form...
Reborn Coffee Provides Second Quarter 2024 Corporate Update and Financial Results
August 20, 2024 08:31 ET
|
REBORN COFFEE, INC.
Reborn Coffee Provides Second Quarter 2024 Corporate Update and Financial Results
AIM ImmunoTech Announces Print Publication and Further Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research
August 20, 2024 08:30 ET
|
AIM ImmunoTech Inc.
Data demonstrate compelling evidence of the immune-stimulatory properties linked to TLR-3 activation through Ampligen Additional commentary published discussing the potential of Ampligen and...
DZS Files Q1 2024 Financial Results
August 20, 2024 08:03 ET
|
DZS
DALLAS, Aug. 20, 2024 (GLOBE NEWSWIRE) -- DZS (OTC: DZSI), a developer of Network Edge, Connectivity and Cloud Software solutions enabling gigabit broadband everywhere, today announced that it has...
Nanox Announces Second Quarter of 2024 Financial Results and Provides Business Update
August 20, 2024 08:00 ET
|
Nano-X Imaging LTD.
Nanox Announces Second Quarter of 2024 Financial Results and
Provides Business Update
GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market
August 20, 2024 07:45 ET
|
GeoVax, Inc.
ATLANTA, GA, Aug. 20, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious...